HAVRIX JUNIOR 720 HEPATITIS A VACCINE 720 U.EI. / 0.5ml injection suspension medication leaflet

J07BC02 • hepatitis A vaccine inactivated adsorbed • Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines

The inactivated adsorbed hepatitis A vaccine is used to prevent infection with the hepatitis A virus (HAV), which can cause acute hepatitis, an inflammatory liver disease. The vaccine contains inactivated hepatitis A viruses adsorbed onto an adjuvant to stimulate a stronger immune response.

The vaccine is administered intramuscularly, usually in two doses, 6-12 months apart. It is recommended for individuals traveling to endemic areas, children, food industry workers, and others at increased risk of infection.

Common side effects include pain at the injection site, mild fever, fatigue, and nausea. In rare cases, severe allergic reactions may occur.

The inactivated adsorbed hepatitis A vaccine is an important preventive measure for reducing the risk of HAV infection and its associated complications, contributing to public health protection.